-
Something wrong with this record ?
Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples
K. Hajkova, B. Jurasek, D. Sykora, T. Palenicek, P. Miksatkova, M. Kuchar,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2011-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2003-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2011-01-01 to 1 year ago
- MeSH
- Chromatography, Liquid methods MeSH
- Cyclohexanones analysis metabolism pharmacokinetics MeSH
- Cyclohexylamines analysis metabolism pharmacokinetics MeSH
- Liquid-Liquid Extraction methods MeSH
- Liver chemistry MeSH
- Calibration MeSH
- Rats MeSH
- Limit of Detection MeSH
- Brain Chemistry MeSH
- Designer Drugs analysis MeSH
- Lung chemistry MeSH
- Tandem Mass Spectrometry methods MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
A new designer drug, a dissociative anesthetic, and a putative N-methyl-D-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid-liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943-1.0000. The calibration curves were linear in the concentration range of 2.5-250 ng g(-1). Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g(-1), respectively. Recovery (80-117%) and matrix effect (94-110%) at 100 ng g(-1) and intra- and inter-day accuracy and precision at low (2.5 ng g(-1)), middle (25 ng g(-1)), and upper (250 ng g(-1)) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000779
- 003
- CZ-PrNML
- 005
- 20170113102616.0
- 007
- ta
- 008
- 170103s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00216-015-9221-1 $2 doi
- 024 7_
- $a 10.1007/s00216-015-9221-1 $2 doi
- 035 __
- $a (PubMed)26661068
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hajkova, Katerina $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
- 245 10
- $a Salting-out-assisted liquid-liquid extraction as a suitable approach for determination of methoxetamine in large sets of tissue samples / $c K. Hajkova, B. Jurasek, D. Sykora, T. Palenicek, P. Miksatkova, M. Kuchar,
- 520 9_
- $a A new designer drug, a dissociative anesthetic, and a putative N-methyl-D-aspartate receptor antagonist, methoxetamine (MXE) noted by the EU Early Warning System has been already identified as a cause of several fatalities worldwide. The primary objective of this work was to develop a suitable sample preparation method allowing for isolation of MXE and its main metabolites in high yields from rat brain, liver, and lungs. For the purpose of the project, MXE and five metabolites were synthesized in-house, specifically O-desmethyl-normethoxetamine, O-desmethylmethoxetamine, dihydro-O-desmethylmethoxetamine, normethoxetamine, and dihydromethoxetamine. A sample preparation procedure consisted in the homogenization of the tissue applying salting-out-assisted liquid-liquid extraction (SALLE). A subsequent liquid chromatography-mass spectrometry (LC-MS) analysis was based on reversed-phased chromatography hyphenated with a triple quad MS system in a positive electrospray mode. Multiple reaction monitoring (MRM) was used for qualification and quantification of the analytes. The quantification was based on the application of an isotopically labeled internal standard, normethoxetamine-d3. The matrix-matched calibrations were prepared for each type of matrix with regression coefficients 0.9943-1.0000. The calibration curves were linear in the concentration range of 2.5-250 ng g(-1). Limits of quantification (LOQs) were estimated as 2.5 and 5 ng g(-1), respectively. Recovery (80-117%) and matrix effect (94-110%) at 100 ng g(-1) and intra- and inter-day accuracy and precision at low (2.5 ng g(-1)), middle (25 ng g(-1)), and upper (250 ng g(-1)) concentration levels for all the analytes in all three types of tissues were also determined. The developed analytical method was applied to a set of real samples gathered in toxicological trials on rats and MXE, and its metabolites were determined successfully.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mozek - chemie $7 D001923
- 650 _2
- $a kalibrace $7 D002138
- 650 _2
- $a chromatografie kapalinová $x metody $7 D002853
- 650 _2
- $a cyklohexanony $x analýza $x metabolismus $x farmakokinetika $7 D003512
- 650 _2
- $a cyklohexylaminy $x analýza $x metabolismus $x farmakokinetika $7 D003514
- 650 _2
- $a nové syntetické drogy $x analýza $7 D015198
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a extrakce kapalina-kapalina $x metody $7 D059625
- 650 _2
- $a játra $x chemie $7 D008099
- 650 _2
- $a plíce $x chemie $7 D008168
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jurasek, Bronislav $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic.
- 700 1_
- $a Sykora, David $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. david.sykora@vscht.cz.
- 700 1_
- $a Palenicek, Tomas $u National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
- 700 1_
- $a Miksatkova, Petra $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
- 700 1_
- $a Kuchar, Martin $u Forensic Laboratory of Biologically Active Substances, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Dejvice, Czech Republic. National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic.
- 773 0_
- $w MED00006638 $t Analytical and bioanalytical chemistry $x 1618-2650 $g Roč. 408, č. 4 (2016), s. 1171-81
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26661068 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170113102716 $b ABA008
- 999 __
- $a ok $b bmc $g 1179919 $s 961346
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 408 $c 4 $d 1171-81 $e 20151211 $i 1618-2650 $m Analytical and bioanalytical chemistry $n Anal Bioanal Chem $x MED00006638
- LZP __
- $a Pubmed-20170103